gene therapy industry

gene therapy industry

featured image of Xcell Biosciences Boosts Gene Therapy Partnership!

Xcell Biosciences Boosts Gene Therapy Partnership!

BIOT

Xcell Biosciences boosts collaboration with AmplifyBio! 🌟 New AVATAR™ system enhances cell therapy manufacturing for tough solid tumors. 🧬🚀

featured image of Rentschler Biopharma Unveils Game-Changing Vector Toolbox!

Rentschler Biopharma Unveils Game-Changing Vector Toolbox!

BIOT

🌟 Rentschler Biopharma unveils a new lentiviral vector toolbox in the UK! 🧬 Custom solutions for gene therapies and cancer treatments! 🔬💡

featured image of Unlock Faster Gene Therapy with In-House Production!

Unlock Faster Gene Therapy with In-House Production!

BIOT

Excerpt: 🌟 In-house CGT production enhances supply chain control, avoiding delays. 🏗️ Modular clean rooms and AI ensure efficient, sterile manufacturing! 🔍

featured image of Revolutionary Digital Twin Boosts AAV Production Efficiency!

Revolutionary Digital Twin Boosts AAV Production Efficiency!

BIOT

🚀 MIT researchers unveil a digital twin for AAV production, optimizing yields and reducing costly experiments in gene therapy! 🌟🧬

featured image of Revolutionizing Therapy: Automation Slashes Production Costs!

Revolutionizing Therapy: Automation Slashes Production Costs!

BIOT

🌟 Discover how automation and standardization in cell and gene therapy can significantly lower production costs and improve accessibility! 💡✅🤝

featured image of Andelyn Biosciences Boosts Gene Therapy Efficiency!

Andelyn Biosciences Boosts Gene Therapy Efficiency!

BIOT

Andelyn Biosciences boosts AAV Curator™ platform with MyoAAV plasmids! 🚀 Enhancing gene therapy for muscles while reducing costs. 💪💰

featured image of Sana Biotechnology Launches New Facility in WA!

Sana Biotechnology Launches New Facility in WA!

BIOT

Sana Biotechnology celebrates a new biomanufacturing facility in Bothell, WA, boosting cell and gene therapy production! 🎉🏭🧑‍🔬📦🤝

featured image of MilliporeSigma Boosts Gene Therapy with $600M Acquisition!

MilliporeSigma Boosts Gene Therapy with $600M Acquisition!

BIOT

MilliporeSigma acquires Mirus Bio for $600 million, boosting viral vector manufacturing and supporting gene therapy advancements! 🚀🔬💡🤝

featured image of Conquering Contamination in Gene Therapy Production

Conquering Contamination in Gene Therapy Production

BIOT

🌟 Overcoming sterility challenges in cell and gene therapy is vital! 🧬 Discover solutions for contamination risks and ensure quality! 🔬💡✨

featured image of Breaking News: Gene Therapy Partnership Expands!

Breaking News: Gene Therapy Partnership Expands!

BIOT

📢 Univercells Technologies and UPENN are expanding their partnership to evaluate gene therapy manufacturing scalability. 🧪 The goal is accessibility and cost reduction. 💪🏭👨‍🔬